Islets from human donors with higher but not lower hemoglobin A1c levels respond to gastrin treatment in vitro
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Islets from human donors with higher but not lower hemoglobin A1c levels respond to gastrin treatment in vitro
Authors
Keywords
Gastrin, HbA1c, Somatostatin, Insulin, Adults, Type 2 diabetes, Gene expression, Diabetes mellitus
Journal
PLoS One
Volume 14, Issue 8, Pages e0221456
Publisher
Public Library of Science (PLoS)
Online
2019-08-22
DOI
10.1371/journal.pone.0221456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival
- (2017) Hirotake Komatsu et al. PLoS One
- Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes
- (2017) A. S. Axelsson et al. Nature Communications
- Evidence for Loss in Identity, De-Differentiation, and Trans-Differentiation of Islet β-Cells in Type 2 Diabetes
- (2017) Chad S. Hunter et al. Frontiers in Genetics
- Isolated human islets require hyperoxia to maintain islet mass, metabolism, and function
- (2016) Hirotake Komatsu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
- (2016) Yue J. Wang et al. Cell Metabolism
- Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
- (2016) Åsa Segerstolpe et al. Cell Metabolism
- Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes
- (2016) Tehila Dahan et al. DIABETES
- Pancreatic β cell identity requires continual repression of non–β cell programs
- (2016) Giselle Domínguez Gutiérrez et al. JOURNAL OF CLINICAL INVESTIGATION
- A Single-Cell Transcriptome Atlas of the Human Pancreas
- (2016) Mauro J. Muraro et al. Cell Systems
- Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control
- (2015) Ilaria Barchetta et al. ACTA DIABETOLOGICA
- The Effect of Proton Pump Inhibitors on Glycated Hemoglobin Levels in Patients With Type 2 Diabetes Mellitus
- (2015) Na Han et al. Canadian Journal of Diabetes
- Inactivating the permanent neonatal diabetes gene Mnx1 switches insulin-producing -cells to a -like fate and reveals a facultative proliferative capacity in aged -cells
- (2015) F. C. Pan et al. DEVELOPMENT
- Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits
- (2015) H. Siebe Spijker et al. DIABETES
- Effect of pantoprazole on insulin secretion in drug-naïve patients with type 2 diabetes
- (2015) Manuel González-Ortiz et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pax4 acts as a key player in pancreas development and plasticity
- (2015) Tiziana Napolitano et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
- (2014) Zhiyu Wang et al. Cell Metabolism
- Pdx1 Maintains β Cell Identity and Function by Repressing an α Cell Program
- (2014) Tao Gao et al. Cell Metabolism
- MafA is critical for maintenance of the mature beta cell phenotype in mice
- (2014) Wataru Nishimura et al. DIABETOLOGIA
- The diabetes gene Hhex maintains -cell differentiation and islet function
- (2014) J. Zhang et al. GENES & DEVELOPMENT
- Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway
- (2014) Barak Blum et al. eLife
- Expression of Mesenchymal and -Cell Phenotypic Markers in Islet -Cells in Recently Diagnosed Diabetes
- (2013) M. G. White et al. DIABETES CARE
- Inactivation of specific β cell transcription factors in type 2 diabetes
- (2013) Shuangli Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Nkx6.1 Is Essential for Maintaining the Functional State of Pancreatic Beta Cells
- (2013) Brandon L. Taylor et al. Cell Reports
- Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
- (2012) K. D. Hove et al. DIABETOLOGIA
- Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Pawan Kumar Singh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
- (2011) Edward Sheen et al. DIGESTIVE DISEASES AND SCIENCES
- Gastrin Treatment Stimulates β-Cell Regeneration and Improves Glucose Tolerance in 95% Pancreatectomized Rats
- (2011) Noèlia Téllez et al. ENDOCRINOLOGY
- Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes
- (2010) T. B. Bödvarsdóttir et al. DIABETOLOGIA
- Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell Survival
- (2010) Jeremy A. Lavine et al. ENDOCRINOLOGY
- Combination Therapy with Glucagon-Like Peptide-1 and Gastrin Induces β-Cell Neogenesis from Pancreatic Duct Cells in Human Islets Transplanted in Immunodeficient Diabetic Mice
- (2008) Wilma L. Suarez-Pinzon et al. CELL TRANSPLANTATION
- In Vitro Proliferation of Cells Derived From Adult Human -Cells Revealed By Cell-Lineage Tracing
- (2008) H. A. Russ et al. DIABETES
- Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin
- (2007) Magali Foucaud et al. REGULATORY PEPTIDES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now